Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer

Xiaoping Li1, Weiliang Zhu, Zhenzhu Chen

  • 1Departments of aPathology bOncology, Zhujiang Hospital, NanFang Medical University cDepartment of Organ Transplantation, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.

Anti-Cancer Drugs
|July 24, 2014
PubMed

Insights

Fibroblast growth factor-inducible 14 (Fn14) promotes small-cell lung cancer (SCLC) growth and chemoresistance by upregulating Bcl-xl via the NF-κB pathway. Targeting Fn14 may offer new therapeutic strategies for SCLC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Fibroblast growth factor-inducible 14 (Fn14) is implicated as an oncogene in various cancers.
  • The role of Fn14 in small-cell lung cancer (SCLC) remains largely unexplored.
  • Understanding Fn14's function in SCLC is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the biological functions of Fn14 in SCLC cell growth and chemoresistance.
  • To elucidate the molecular mechanisms underlying Fn14's effects in SCLC.
  • To assess Fn14 as a potential therapeutic target for SCLC.

Main Methods:

  • Immunohistochemistry was used to examine Fn14 expression in 51 SCLC tissue samples.
  • Fn14 was overexpressed or knocked down in SCLC cell lines (H69, H446, H69AR, H446AR) to study its impact on cell growth and chemoresistance.
  • Cell apoptosis, cell cycle progression, Bcl-xl expression, and nuclear factor-κB (NF-κB) activity were analyzed.

Main Results:

  • Fn14 was expressed in 50.98% of SCLC cases and associated with advanced pathologic stage and shorter survival.
  • Overexpression of Fn14 promoted SCLC cell growth, enhanced multidrug resistance, decreased apoptosis, and increased G2-phase accumulation.
  • Inhibition of Fn14 reduced cell growth, sensitized cells to chemotherapy, increased apoptosis, and induced G1/S phase arrest, mediated by the NF-κB/Bcl-xl pathway.

Conclusions:

  • Fn14 plays a significant role in promoting SCLC cell proliferation and chemoresistance.
  • The Fn14 signaling pathway, involving NF-κB and Bcl-xl, is a key mechanism in SCLC progression.
  • Fn14 represents a promising novel therapeutic target for SCLC treatment.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.1K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
Cells Coordinate Growth and Proliferation02:36

Cells Coordinate Growth and Proliferation

Cell size is a significant factor impacting cellular design, function, and fitness. There exists some internal coordination by which cells double their masses before division, thus, achieving homeostasis. Coordination between cell growth and proliferation depends on the checkpoints in between cell cycle phases. Loss of coordination or failure in the checkpoint mechanism can drive the cell to uncontrolled growth and loss of cellular function. Like dividing cells that coordinate cellular growth,...
3.8K